2023 ICD-10-CM Diagnosis Code D02

Carcinoma in situ of middle ear and respiratory system

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • D02 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM D02 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of D02 - other international versions of ICD-10 D02 may differ.
Use Additional
Use Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
  • code to identify:
  • exposure to environmental tobacco smoke (
    ICD-10-CM Diagnosis Code Z77.22

    Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Exposure to second hand tobacco smoke (acute) (chronic)
    • Passive smoking (acute) (chronic)
    Type 1 Excludes
    Type 2 Excludes
    • occupational exposure to environmental tobacco smoke (Z57.31)
    Z77.22
    )
  • exposure to tobacco smoke in the perinatal period (
    ICD-10-CM Diagnosis Code P96.81

    Exposure to (parental) (environmental) tobacco smoke in the perinatal period

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Code on Newborn Record
    Type 2 Excludes
    • newborn affected by in utero exposure to tobacco (P04.2)
    • exposure to environmental tobacco smoke after the perinatal period (Z77.22)
    P96.81
    )
  • history of tobacco dependence (
    ICD-10-CM Diagnosis Code Z87.891

    Personal history of nicotine dependence

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 1 Excludes
    • current nicotine dependence (F17.2-)
    Z87.891
    )
  • occupational exposure to environmental tobacco smoke (
    ICD-10-CM Diagnosis Code Z57.31

    Occupational exposure to environmental tobacco smoke

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 2 Excludes
    • exposure to environmental tobacco smoke (Z77.22)
    Z57.31
    )
  • tobacco dependence (
    ICD-10-CM Diagnosis Code F17
    • F17 Nicotine dependence
      • F17.2 Nicotine dependence
        • F17.20 Nicotine dependence, unspecified
          • F17.200 Nicotine dependence, unspecified, uncomplicat...
          • F17.201 Nicotine dependence, unspecified, in remissio...
          • F17.203 Nicotine dependence unspecified, with withdra...
          • F17.208 Nicotine dependence, unspecified, with other ...
          • F17.209 Nicotine dependence, unspecified, with unspec...
        • F17.21 Nicotine dependence, cigarettes
          • F17.210 Nicotine dependence, cigarettes, uncomplicate...
          • F17.211 Nicotine dependence, cigarettes, in remission...
          • F17.213 Nicotine dependence, cigarettes, with withdra...
          • F17.218 Nicotine dependence, cigarettes, with other n...
          • F17.219 Nicotine dependence, cigarettes, with unspeci...
        • F17.22 Nicotine dependence, chewing tobacco
          • F17.220 Nicotine dependence, chewing tobacco, uncompl...
          • F17.221 Nicotine dependence, chewing tobacco, in remi...
          • F17.223 Nicotine dependence, chewing tobacco, with wi...
          • F17.228 Nicotine dependence, chewing tobacco, with ot...
          • F17.229 Nicotine dependence, chewing tobacco, with un...
        • F17.29 Nicotine dependence, other tobacco product
          • F17.290 Nicotine dependence, other tobacco product, u...
          • F17.291 Nicotine dependence, other tobacco product, i...
          • F17.293 Nicotine dependence, other tobacco product, w...
          • F17.298 Nicotine dependence, other tobacco product, w...
          • F17.299 Nicotine dependence, other tobacco product, w...
    F17.-
    )
  • tobacco use (
    ICD-10-CM Diagnosis Code Z72.0

    Tobacco use

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Applicable To
    • Tobacco use NOS
    Type 1 Excludes
    • history of tobacco dependence (Z87.891)
    • nicotine dependence (F17.2-)
    • tobacco dependence (F17.2-)
    • tobacco use during pregnancy (O99.33-)
    Z72.0
    )
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D02. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • melanoma in situ (
    ICD-10-CM Diagnosis Code D03
    • D03 Melanoma in situ
      • D03.0 Melanoma in situ of lip
      • D03.1 Melanoma in situ of eyelid, including canthus...
        • D03.10 Melanoma in situ of unspecified eyelid, inclu...
        • D03.11 Melanoma in situ of right eyelid, including c...
          • D03.111 Melanoma in situ of right upper eyelid, inclu...
          • D03.112 Melanoma in situ of right lower eyelid, inclu...
        • D03.12 Melanoma in situ of left eyelid, including ca...
          • D03.121 Melanoma in situ of left upper eyelid, includ...
          • D03.122 Melanoma in situ of left lower eyelid, includ...
      • D03.2 Melanoma in situ of ear and external auricula...
        • D03.20 Melanoma in situ of unspecified ear and exter...
        • D03.21 Melanoma in situ of right ear and external au...
        • D03.22 Melanoma in situ of left ear and external aur...
      • D03.3 Melanoma in situ of other and unspecified par...
        • D03.30 Melanoma in situ of unspecified part of face
        • D03.39 Melanoma in situ of other parts of face
      • D03.4 Melanoma in situ of scalp and neck
      • D03.5 Melanoma in situ of trunk
        • D03.51 Melanoma in situ of anal skin
        • D03.52 Melanoma in situ of breast (skin) (soft tissu...
        • D03.59 Melanoma in situ of other part of trunk
      • D03.6 Melanoma in situ of upper limb, including sho...
        • D03.60 Melanoma in situ of unspecified upper limb, i...
        • D03.61 Melanoma in situ of right upper limb, includi...
        • D03.62 Melanoma in situ of left upper limb, includin...
      • D03.7 Melanoma in situ of lower limb, including hip...
        • D03.70 Melanoma in situ of unspecified lower limb, i...
        • D03.71 Melanoma in situ of right lower limb, includi...
        • D03.72 Melanoma in situ of left lower limb, includin...
      • D03.8 Melanoma in situ of other sites
      • D03.9 Melanoma in situ, unspecified
    D03.-
    )
The following code(s) above D02 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D02:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2023 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D02:
  • Applicable To: Z86.005
    ICD-10-CM Diagnosis Code Z86.005

    Personal history of in-situ neoplasm of middle ear and respiratory system

      2020 - New Code 2021 2022 2023 Billable/Specific Code POA Exempt
    Applicable To
    • Conditions classifiable to D02
ICD-10-CM Codes Adjacent To D02
D01.0 Carcinoma in situ of colon
D01.1 Carcinoma in situ of rectosigmoid junction
D01.2 Carcinoma in situ of rectum
D01.3 Carcinoma in situ of anus and anal canal
D01.4 Carcinoma in situ of other and unspecified parts of intestine
D01.40 Carcinoma in situ of unspecified part of intestine
D01.49 Carcinoma in situ of other parts of intestine
D01.5 Carcinoma in situ of liver, gallbladder and bile ducts
D01.7 Carcinoma in situ of other specified digestive organs
D01.9 Carcinoma in situ of digestive organ, unspecified
D02 Carcinoma in situ of middle ear and respiratory system
D02.0 Carcinoma in situ of larynx
D02.1 Carcinoma in situ of trachea
D02.2 Carcinoma in situ of bronchus and lung
D02.20 Carcinoma in situ of unspecified bronchus and lung
D02.21 Carcinoma in situ of right bronchus and lung
D02.22 Carcinoma in situ of left bronchus and lung
D02.3 Carcinoma in situ of other parts of respiratory system
D02.4 Carcinoma in situ of respiratory system, unspecified
D03 Melanoma in situ
D03.0 Melanoma in situ of lip

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.